scispace - formally typeset
S

Salomeh Jelveh

Researcher at Princess Margaret Cancer Centre

Publications -  23
Citations -  1814

Salomeh Jelveh is an academic researcher from Princess Margaret Cancer Centre. The author has contributed to research in topics: Lung injury & Radiation-induced lung injury. The author has an hindex of 15, co-authored 22 publications receiving 1619 citations. Previous affiliations of Salomeh Jelveh include University of Toronto & University Health Network.

Papers
More filters
Journal ArticleDOI

Gold Nanoparticles as Radiation Sensitizers in Cancer Therapy

TL;DR: The results of in vitro studies that focus on the radiosensitization properties of nanoparticles in the size range from 14–74 nm will enable the optimization of gold nanoparticle-based sensitizers for use in therapy.
Journal ArticleDOI

Divergent clonal selection dominates medulloblastoma at recurrence

A. Sorana Morrissy, +141 more
- 21 Jan 2016 - 
TL;DR: Targeted therapy is unlikely to be effective in the absence of the target, therefore the results offer a simple, proximal, and remediable explanation for the failure of prior clinical trials of targeted therapy.
Journal ArticleDOI

Informatics Platform for Global Proteomic Profiling and Biomarker Discovery Using Liquid Chromatography-Tandem Mass Spectrometry

TL;DR: In this article, an integrated suite of algorithms, statistical methods, and computer applications is developed to support large-scale LC-MS-based gel-free shotgun profiling of complex protein mixtures using basic experimental procedures.
Journal ArticleDOI

Characterization of image quality and image-guidance performance of a preclinical microirradiator

TL;DR: The micro-IGRT unit provides soft-tissue imaging of small-animal anatomy at acceptable imaging doses (< or =1 cGy).
Journal ArticleDOI

Gold Nanostructures as a Platform for Combinational Therapy in Future Cancer Therapeutics

TL;DR: A multifunctional platform based on gold nanostructures with targeting ligands, therapeutic molecules, and imaging contrast agents, holds an array of promising directions for cancer research.